ging during the study period. Results: eEduHeart I will be one of the first studies to report on the added value of eLearning. Conclusions: If the intervention is proven effective, current cardiac telerehabilitation programs can be augmented by including eLearning, too. The platform can then be used as a model for other chronic diseases in which patient education plays a key role.
Introduction
Ischemic heart disease is a leading cause of death worldwide. Each year, more than 7 million people experience a myocardial infarction, and 1-year mortality rates are still in the range of 10% [1] . Secondary prevention by means of cardiac rehabilitation (CR) is recommended by the American Heart Association and the European Society of Cardiology (class IB recommendation) after the initial coronary event [2] . Although proven effective, <50% of eligible patients attend CR, as reported in EU-ROASPIRE IV (the European Society of Cardiology survey on the therapeutic management of ischemic heart dis-ease patients from 24 European countries) [3] . Patients regularly choose not to attend center-based rehabilitation due to lack of access to transport, ill-health, time, and scheduling commitments associated with returning to work or reimbursement issues [4] . This leads to suboptimal efficacy of secondary cardiovascular prevention.
Innovative care delivery strategies such as cardiac telerehabilitation have been proposed as potential adjuncts/alternatives to optimize rehabilitation uptake and long-term adherence rates [5] . In telerehabilitation, the patient is not restricted to the hospital or rehabilitation center environment for CR, but rehabilitates remotely by using one or several devices monitoring and communicating patient-specific information to the caregivers. In its most comprehensive format, it includes both telemonitoring (i.e. remote monitoring), telecoaching (i.e. coaching from a distance by email/SMS/telephone), social interaction, and eLearning, and focuses on all CR core components (physical activity, behavioral change, risk factor control, nutritional counseling, psychosocial support, and education).
Recent research findings on cardiac telerehabilitation for coronary artery disease (CAD) showed noninferiority and/or superiority of telerehabilitation on adherence to physical activity guidelines, quality of life, and cardiovascular readmission rates [5] [6] [7] [8] . In these studies, however, telemonitoring and telecoaching were the two focus areas mostly applied. The specific role and value of eLearning were hardly assessed [9, 10] . Proper patient education, however, seems highly relevant. Patients who have a clear understanding of their after-hospital care instructions are 30% less likely to be readmitted or to visit the emergency department than patients who lack this information [11] . Unstructured conventional ways for informing/educating cardiac patients, small time dedicated to education, and poor-quality explanations are determinants of poor implementation of secondary preventive measures [12] .
A specific challenge for internet-based telemedical interventions appears to be the low uptake and high attrition rates [13] . Antypas et al. [13] investigated an internet-and mobile-based tailored intervention to enhance the maintenance of physical activity following cardiac rehabilitation. They could only enroll 69 patients (out of 255 patients initially planned), and the enrolled patients had an unexpectedly high attrition rate (with 19/69 patients responding at the 3-month follow-up). Therefore, special attention to telemedical intervention characteristics that can increase patient uptake and adherence is needed.
The eEduHeart I trial is a randomized, controlled, multicenter study (n = 1,000) designed to investigate the effectiveness of the addition of eLearning to conventional cardiac care compared to conventional cardiac care alone. In eLearning, the patients are taught about the etiology, pathophysiology, clinical presentation, and medical treatment of their cardiac disease using a repository of video material on a specifically developed web-based cardiac eLearning platform. The primary hypothesis is that the addition of eLearning improves patients' health-related quality of life with greater magnitude than conventional cardiac care alone. Secondary endpoints include cardiac pathology-specific knowledge level, eLearning platform user experience, and eLearning platform usage.
Methods
Study Design eEduHeart I is a multicenter, prospective, randomized, controlled clinical trial recruiting 1,000 stable CAD patients. Patients with stable CAD are defined as (a) patients in the revascularized, stabilized, and asymptomatic phase following an acute coronary syndrome (ACS) (unstable angina, non-ST elevation ACS, or STelevation ACS) or (b) patients initially presenting with stable angina who are revascularized or asymptomatic under optimal medical treatment (not amenable to revascularization) [2] . Patients are randomized in equal proportions to one of two groups: web-based eLearning in addition to conventional cardiac care (intervention group) or conventional cardiac care alone (control group) ( fig. 1 ). Patients are enrolled after hospitalization for the initial coronary event. All included patients underwent invasive coronary angiography. Obstructive CAD for which revascularization was indicated was defined as: (i) left main disease with stenosis >50%, (ii) proximal LAD stenosis >50%, (iii) two-or three-vessel disease with stenosis >50% and with impaired LV function (LVEF <40%), (iv) single remaining patent coronary artery with stenosis >50%, and/or (v) any coronary stenosis >50% in the presence of limiting angina or angina equivalent unresponsive to medical therapy [14] . They are followed for a minimum duration of 3 months. Eligible eEduHeart I patients are expected to be recruited from January 2016 to July 2017.
Patients are recruited from the Cardiology Departments of two Belgian community clinics [Jessa Hospital (Hasselt) and Hospital East-Limburg (Genk)]. The Jessa Hospital acts as the coordinating center for the trial. Each participating site is responsible for the recruitment and scheduled follow-up of patients but also for contingency patient management. Both sites have the capability for effective recruitment (yearly number of hospitalizations for CAD in Jessa Hospital: >1,200 and Hospital East-Limburg: >1,500). However, premature closure of a recruiting site will be considered if (1) the recruitment rate is not sufficient, (2) the conduct of the study is not compliant with the study protocol, or (3) data quality is not sufficient. The premature closure of a site will be decided by the principal investigator. In this case, reserve trail sites, suitable for inclusion in eEduHeart I, will be contacted. eEduHeart I's principal investigator verifies on a monthly basis patient inclusion rate in both recruiting hospitals, study conductance, and data quality by reviewing the clinical trial database. In case of a patient inclusion rate <60 patients/month for 2 consecutive months (for all recruiting centers combined), one additional reserve trial site is opened. Two backup institutions (each with >700 hospitalizations for CAD per year) were contacted prior to the start of eEduHeart I. Both confirmed their willingness to serve as reserve trial site. Upon the decision to include a backup institution, approval from the institution's ethical committee to conduct eEduHeart I is asked for. Once approval has been obtained (this is expected 2 weeks after submission of the request), patient inclusion can start. In both reserve trial sites, a researcher is available to ensure patient inclusion and follow-up during the eEduHeart I study period.
The study is conducted in accordance with the principles stated in the Declaration of Helsinki (reviewed version of 2008), and local and national regulations. Written informed consent was obtained from all patients by predetermined site-specific eEduHeart I investigators prior to study enrollment. The study is approved by the appropriate ethics committee (Jessa Ethics Committee; reference No. 15.82/cardio15.11; dd. 20 November 2015, version 2). eEduHeart I is registered at ClinicalTrials.gov NCT02475967 (registration date June 10, 2015) .
eEduHeart I adheres to the relevant standards of reporting. A completed CONSORT checklist can be found in online supplementary table 1 (for all online suppl. material, see www. karger.com/doi/10.1159/000448393). The study protocol complies with the SPIRIT guidelines, the checklist of which can be found in online supplementary table 2.
Study Population
Patients with CAD, for which they were treated conservatively, a percutaneous coronary intervention, or coronary artery bypass grafting who signed the informed consent form are eligible to participate. They are at least 18 years old and must have a personal computer with internet connection. The main exclusion criteria are: insufficient reading and writing language skills in the relevant language (Dutch), the presence of preexisting dementia, cognitive impairment, and/or visual and/or auditory impairments that render the patient unable to understand the eLearning platform content.
Sample Size
The sample size calculation is based on a small effect size of 0.1 for the primary outcome measure [health-related quality of life (HeartQoL) score)] expected [8] . In order to attain a minimal power of 80%, at an α error probability <0.05, 998 patients should be recruited when taking into account a dropout rate of 5% during follow-up.
Randomization
During/after hospitalization for the initial coronary event, patients will be recruited by predetermined site-specific eEduHeart I investigators. They will first inform the patient about the study and hand out study information. Patients will be randomized (1: 1) to the intervention group or the control group using sequentially numbered, opaque, sealed envelopes. Block randomization is used to ascertain equal group distribution in the different recruiting hospitals.
Study Intervention
Patients in the intervention group are provided with access to a web-based cardiac eLearning platform in addition to conventional cardiac care.
The Cardiac eLearning Platform Intervention patients are given six eLearning platform entry codes and passwords within 2 days after randomization. They are provided with background and general information regarding the study design, content, and main hypotheses of eEduHeart I. Patients are taught how to go to the web-based platform on their personal computer and how to enter it. The codes and passwords enable unrestricted platform access for a 1-month period starting from the date of the first platform log-in. One code and password is intended for study patient use only, the others can be distributed to family members and/or friends, thereby enabling a 1-month platform access for them, too.
The eLearning platform was designed and developed using a user-centric approach. Special attention was given to ensure a user-friendly platform design also for elderly patients not familiar with internet-based interventions. The eLearning platform content was based on the CR core components for CAD patients defined by guidelines of the European Society of Cardiology and the European Association for Cardiovascular Prevention and Rehabilitation [15, 16] . It contains 20 main video units. Each video unit focuses on a different topic relevant in secondary prevention for ischemic heart disease. The following topics are present: (i) smoking as a risk factor; (ii) cardiovascular risk factors; (iii) drug therapy and side effects; (iv) signs and symptoms of CAD; (v) lifestyle behavior change after the coronary event; (vi) heart-friendly diet; (vi) exercise training; (vii) cardiac rehabilitation; (viii) cardiac telerehabilitation; (ix) leisure time activities; (x) anxiety and depression; (xi) social support; (xii) importance of regular medical follow-up; (xiii) quality of life; (xiv) driving a car after the coronary event; (xv) travel; (xvi) return to work; (xvii) discouraged activities; (xviii) being a caregiver for a CAD patient; (xix) physical restrictions after the coronary event, and (xx) family and friends. Each video unit is composed of three videos, one or two with (a) (para) medical caregiver(s) and one or two with patient(s). The aim of the videos in which the (para)medics participate is to provide eEduHeart I study patients with educational content on the video unit topic. The videos in which patients participate themselves intend to enable the sharing of subjective experiences. Video length is 1-2 min. Study patients can watch each video (unit) more than once if preferred.
Conventional Cardiac Care
Patients in both the control and intervention group are invited to follow the conventional center-based CR program, including a total of 45 multidisciplinary sessions focusing on nutritional counseling, psychosocial well-being, behavioral change, risk factor modification, education, and exercise training. One standard group session on nutritional counseling can be supplemented by one or two face-to-face session(s) according to patient preferences. The CR center's psychologist invites all patients for a basic psychological screening consultation (aiming to detect anxiety, depression, and personality disorders) and also follow-up visits if indicated desirable by the patient. The exercise training sessions are scheduled 2-3 times/week, with an average session duration of 45 min. Exercise modalities include both endurance training (walking, running, and cycling) and resistance training. Training intensity is progressively increased from the first ventilatory threshold to the respiratory compensation point. Only one 60-min educational session is provided to CR patients at the start of CR. The educational session is performed by the hospital's cardiologist/rehabilitation physician and covers the following topics: physiology and pathology of the cardiovascular system (including CAD, rhythm disorders, heart failure, and valvular disease), signs and symptoms of cardiac disease, drug therapy, and side effects. If case control and/or intervention group patients decide not to participate in conventional CR, they have standard biannual follow-up visits with the treating cardiologist only.
Outcome Measures
For an overview of all measures over the different measurement time points, please see SPIRIT table 1 . Each premature termination of follow-up will be documented by the responsible investigator. If possible, date, circumstances of, and reason for the termination will be documented in detail and communicated to the principal investigator.
Demographic Characteristics
The background variables that are assessed include age, gender, education, profession, cardiovascular risk factor profile, comorbidities, type of initial coronary event (ST or non ST-elevation myocardial infarction, and unstable and stable angina), initial cardiac treatment option (percutaneous coronary intervention, coronary artery bypass grafting, or medical treatment), number and type of coronary arteries involved, and inclusion in or exclusion of conventional CR.
Health-Related Quality of Life The 14-item offline-validated HeartQoL questionnaire will be used to assess health-related quality of life [17] . Mean ± SD scores will be calculated for both the physical (10-item) and emotional (4-item) subscale. The proportion of patients at the floor ('floor effect', defined as the lowest possible score on the questionnaire) and at the ceiling ('ceiling effect', defined as the best possible score) will be determined to assess sensitivity to positive and negative changes in health-related quality of life. ↔ Assessments Demographic characteristics X Health-related quality of life X X X Pathology-specific knowledge X X X Platform user experience (intervention group only) X Pathology-Specific Knowledge Pathology-specific knowledge will be evaluated using the eEduHeart knowledge questionnaire. This questionnaire was elaborated in a multistep process involving all relevant CAD management (para)medical stakeholders of the Jessa Hospital (including 1 cardiologist, 1 rehabilitation physician, 2 CR physiotherapists, 2 dieticians, 1 psychologist, and 1 social nurse). For each step, all (para)medical members evaluated the eEduHeart knowledge questionnaire questions in their field of expertise for question clarity, understandability, robustness, and relevance. The pre-final version of the questionnaire was pilot tested in a sample of CAD patients, after which 8/14 questions were rephrased to improve patient understandability. The final eEduHeart questionnaire version includes 14 multiple choice questions (3 alternative answers/question), all relating to the content of ≥ 1 of the 20 cardiac eLearning platform video units: cardiovascular risk factors (question 1); drug therapy and side effects (questions 2 and 3); signs and symptoms of CAD (question 4 and 14); lifestyle behavioral changes after a coronary event (questions 5 and 6); smoking as a risk factor (questions 7-9); cardiac rehabilitation (question 10); heart-friendly diet (questions 11 and 12), and exercise training (question 13).
eLearning Platform User Experience User experience of the web-based eLearning platform will be performed using the validated user experience questionnaire (UEQ) [18] . The UEQ consists of 26 items, and items covering the same topic are pooled in the same scale (with a total of six scales: attractiveness, perspicuity, efficiency, dependability, stimulation, and novelty). The items are scaled from -3 to +3. Thus, -3 represents the most negative answer, 0 a neutral answer, and +3 the most positive answer. Mean ± SD scores will be calculated for each question separately. Also, mean ± SD scores will be calculated for each scale. Cronbach's α coefficients (α = n * r/1 + (n − 1) * r, where r is the mean correlation of the items in a scale and n is the number of items in a scale, will be calculated for the six scales of the UEQ. The α coefficient is a measure for the consistency of a scale, i.e. it indicates that all items in a scale measure a similar construct.
eLearning Platform Usage Data on the eLearning platform usage will be gathered through web logging during the whole study period. The number of log-ins per code (i.e. patient or family and friends), the total time logged in, the number and type of video units watched, and the time viewing each specific video unit will be registered.
Data Management
Individually registered patient information will be entered into a database at the coordinating center (Jessa Hospital). Only allocation number is used for subject identification. The key to patient identity will be at each participating center only. All information will be stored without name and personal identification, or other identifying information. The principal investigator of eEduHeart I must permit all authorized third parties access to the trial site and insight into the trial subjects' source data.
Study Endpoints
The primary endpoint of eEduHeart I is the health-related quality of life assessed by HeartQoL at 1 and 3 months. The secondary endpoints include:
• eEduHeart pathology-specific knowledge score at 1 and 3 months, • UEQ eLearning platform user experience score at 1 month, and • eLearning platform total log-in time during the whole study period. All outcome assessors will be blinded to group allocation.
All patients will be contacted by telephone at the 1-and 3-month follow-ups. During these phone calls, patients will be asked to answer the predefined questionnaire questions. The questionnaires will only be sent to the patients by email, if they explicitly ask for it. Furthermore, the phone calls will be used to ask for technical problems related to the log-in and/or use of the platform. When needed, technical support will be provided.
Trial Status
The eEduHeart I study protocol and amendments were approved by the hospital's ethics committee prior to study start (B243201526134). The study is currently recruiting patients.
Statistical Analysis
Data analysis will be performed using SPSS (version 22) according to the intention-to-treat principle by assigned treatment group. Nonparametric alternatives will be used for parametric statistics in case normality assumptions for the latter are violated. The Shapiro-Wilk test will be applied to assess normality. Repeated-measures ANOVA (parametric) or Friedman's ANOVA (nonparametric) will be used for within-group analysis (compare multiple dependent means); independent t tests (parametric) or Mann-Whitney U tests (nonparametric) for between-group analysis; χ 2 tests in case of categorical variables, and Fisher's exact tests when expected frequencies are small. The significance level for tests will be 2-sided α of 0.05. Subgroup analyses will be performed to determine if the benefit of the intervention differs between groups for educational level, profession, and whether or not the patient was included in conventional CR. Dose-response analyses will be conducted with linear regression to see if the intervention effect depends on the total time logged in on the eLearning platform. Effect sizes for the HeartQoL questionnaire will be reported using the standardized response mean methodology [standardized response mean = (A -B)/D], where A and B are the mean scores at time 2 and time 1, respectively, and D represents the score change standard deviation [17] . All available data will be used; no data imputation will be performed for missing values.
Discussion
The eEduHeart I trial will investigate the effectiveness of the addition of eLearning using a specifically developed cardiac web-based eLearning platform in addition to conventional cardiac care. eLearning comprises one of the components of a comprehensive cardiac telerehabilitation program. However, to the best of our knowledge, its specific role and value were hardly assessed.
Study Strengths
The study follow-up duration is 3 months, while the patients' eLearning platform access period is only 1 month. This will allow us to investigate the medium-term persistence of the platform's educational value. Simple and widespread technology was used for the construction of the eLearning platform, thereby not challenging our users that will be middle-aged to senior patients. The educational content of the platform is very robust and based on official recommendations by the European Society of Cardiology and the European Association of Cardiovascular Prevention and Rehabilitation. Another strength of the eEduHeart I trial is the level of user involvement in the eLearning platform development. As the platform aims to fulfil the demands of both the rehabilitation center (para)medics and the patients, it is by definition user initiated. We succeeded in a high level of user involvement by encouraging both caregiver and patient participation in the video elaboration and hence platform development. The study results are expected to have high external generalizability, since the inclusion criteria are very broad. This will increase the relevance of the results during the implementation of the intervention outside the strictly controlled clinical trial setting.
Expected Outcomes and Future Contributions
The eEduHeart I trial addresses patients with CAD, one of the most important noncommunicable diseases worldwide. It aims to provide evidence on the efficacy of a cardiac web-based eLearning platform for secondary prevention with high reach. If the intervention proves to be effective, the eLearning platform can be offered to patients in other cardiac rehabilitation centers. The methodology used can also be applied to other chronic diseases in which patient education plays a key role.
